1
ammonium ionophores and reported potassium selectivity com-
capillary melting point apparatus and are not corrected. H and
parable to nonactin and enhanced selectivity for ammonium over
13C NMR spectra were recorded with a Bruker Avance 400 in
CDCl3 unless otherwise noted. All solvents and reagents were
analytical reagent grade and used as supplied from Aldrich
Chemical Co. PVC, nitrophenyl octyl ether (NPOE), dioctyl
phthalate (DOP), potassium tetrakis(4-chlorophenyl)borate
pot
sodium ion (log
K
+ ) -3.9).13 Similarly, others have used 19-
NH4
crown-6 structures with decalino blocking groups to control
selectivity, reporting increased selectivity for ammonium over both
smaller and larger cations.14
Our approach to the design and synthesis of ammonium
ionophores has, as with Lehn and others, focused on the
incorporation of hydrogen bond donors in tetrahedrally symmetric
complexation sites. Given the structural complexity of some of
the synthetic ionophores reported, we have used a molecular motif
that both lends itself to straightforward synthesis and allows
structural modifications to be incorporated without substantial
changes in synthetic strategy. Our experience to date, as well as
that of others,15-19 has shown that ionophores based on cyclic
peptide and depsipeptide structures, i.e., those that are similar to
natural ionophores, can be readily synthesized in high yield by
either solution- or solid-phase methods.
(KtpClPB), and
Fluka AG (Buch, Switzerland). Amino acids
were purchased from Calbiochem-Novabiochem Corp. Buffers
were prepared with deionized water (18 MΩ‚cm).
D
-hydroxyisovaleric acid were purchased form
- and -valine-N-fmoc
L
D
Molecular Modeling Calculations. Molecular modeling was
performed on an SGI 320 running Windows NT. Calculations were
carried out using the Molecular Operating Environment version
2000.02 computing package (Chemical Computing Group Inc.,
Montreal, PQ, Canada). Structures were minimized first using the
AMBER94 potential control under a solvent dielectric of 5.
PEF95SAC was used to calculate partial charges. Minimized
structures were then subjected to a 30-ps molecular dynamics
simulation employing the NVT statistical ensemble. The structures
were heated to 400 K, equilibrated at 310 K, and cooled to 290 K
in the dynamics thermal cycle at a rate of 10 K/ ps. The lowest
energy structures obtained from these dynamics calculations were
then minimized again. Using the minimized structures, docking
energies of the ammonium and potassium cations were calculated
by employing the default parameters supplied with the program.
Synthesis of Ionophore (Scheme 1 ). A detailed description
of the synthesis and purification of the cyclodepsipeptide IV is
provided in the Supporting Information. Briefly, two building
blocks, I and II, were formed in solution from the corresponding
In the work reported here, we have taken valinomycin as our
inspiration for the design of a new ammonium ion-specific
ionophore. Valinomycin is a naturally occurring antibiotic having
high selectivity for potassium ions. It has a cyclic depsipeptide
structure consisting of alternating amide and ester units (6 of each,
12 in total) and has been synthesized on a solid-phase support.19
Valinomycin preorganizes through hydrogen bonding of its amide
carbonyl groups to form a pocket that presents its six ester
carbonyl groups as sources of electrostatic stabilization for
potassium ions.20 Thus, the pocket provides an octahedral-type
complexation site with a size that is a close match to the estimated
ionic radius of potassium (1.33 Å). We report here the synthesis
of an ammonium ion-specific ionophore, IV, which has some of
the same structural elements as valinomycin. IV is a cyclic
depsipeptide consisting of alternating amide and ester groups
(three of each, six in all) which is in effect, half of the valinomycin
structure. IV does not fold onto itself and therefore it provides a
complexation site that is approximately the same size as valino-
mycin, a necessary feature because the ammonium ionic radius
(1.43 Å) is comparable to that of potassium.11 An important
difference though, is that IV is not capable of providing an
octahedral binding site. However, it has hydrogen bond donors
arranged tetrahedrally (necessary for ammonium complexation),
and it is this distinction that we expected to allow the ionophore
to discriminate efficiently between potassium and ammonium ions.
Below we describe the synthesis of IV, the incorporation of
this ionophore into a planar ISE sensor format, testing of the
potentiometric response of the electrode in a commercial clinical
diagnostic “point-of-care” instrument, and the results of selectivity
studies for ammonium versus other metal cations.
L-lactic acid,
D-valine-N-fmoc residues (I) and D-hydroxyisovaleric
acid, -valine-N-fmoc residues (II). These were coupled sequen-
L
tially as I-II-I onto a Wang resin, then cleaved to give III, and
subsequently cyclized to give the title compound, IV.
ISE Membrane and Electrode P reparation. Four mem-
brane cocktails were prepared to test IV. The specific formulations
are as follows: M1, 69/ 30/ 1 wt % of NPOE/ PVC/ IV; M2, same
as M1 with 50 mol % of KtpClPB to IV; M3, 69/ 30/ 1 wt % of DOP/
PVC/ IV; M4, same as M3 with 50 mol % KtpClPB to IV.
Membrane cocktails were prepared as 10 wt % solutions in THF.
The base electrodes were constructed in a thick-film planar
format21 using a polymeric internal electrolyte layer.22,23 A single
wafer composed of 100 individual electrode elements was used
for the sensor construction. The polymer, methacrylamido-
propylmethylammonium chloride (MAPTAC), for the internal
electrolyte was prepared as a 10 wt % solution in EtOH, spun on
to the planar wafer at 750 rpm for 30 s, and allowed to dry for 1
h before membrane deposition. Internal electrolyte thickness was
∼3.5 µm. The wafer was then quartered giving 4 wafers of 25
sensors each. Membrane cocktails were deposited (0.9 mL) onto
the wafers and allowed to cure for 24 h before use, giving a
membrane thickness of ∼105 µm. The planar wafers were
singulated by hand, giving 25 sensors for each formulation.
ISE Testing. The sensors were housed in the proprietary flow-
through cell used with the Bayer Diagnostics Rapidpoint 400
critical care system. This system uses a saturated Ag/ AgCl
reference cell. Two flow cells were constructed, which contained
EXPERIMENTAL SECTION
Reagents. Mass spectra were performed by Synpep Corp.
(Dublin, CA). Melting points are measured in a Mel-Temp
(15) Kubik, S.; Goddard, R. J. Org. Chem. 1 9 9 9 , 64, 9475-9486.
(16) Ghadiri, M. R.; Granja, J. R.; Milligan, R. A.; McRee, D. E.; Khazanovich, N.
Nature 1 9 9 3 , 366, 324-327.
(17) Granja, J. R.; Ghadiri, M. R. J. Am. Chem. Soc. 1 9 9 4 , 116, 10785-10786.
(18) Hartgerink, J. D.; Granja, J. R.; Milligan, R. A.; Ghadiri, M. R. J. Am. Chem.
Soc. 1 9 9 6 , 118, 43-50.
(19) Isin, B. F.; Merrifield, R. B.; Tosteson, D. C. J. Am. Chem. Soc. 1 9 6 9 , 91,
(21) Benco, J. S.; Foos, J. U.S. Patent 5554272, 1996.
(22) Chan, A. D. C. U.S. Patent 5804049, 1998.
(23) Chan, A. D. C. U.S. Patent 5911862, 1999.
2691-2695.
(20) Pullman, A. Chem. Rev. 1 9 9 1 , 91, 793-812.
Analytical Chemistry, Vol. 75, No. 1, January 1, 2003 153